Search Results 1601-1610 of 14746 for anti-TNF drugs

1. Overview - Military Medicine Program - Mayo Clinic Research

   We also partner with experts in research and clinical care to advance treatment options and develop products that directly improve health care for military ...

2. A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of Chronic Spontaneous Urticaria in Adults Inadequately Controlled by H1-antihistamines - Mayo Clinic

   anti-inflammatory drugs (NSAID), that was clinically relevant (e.g. requiring hospitalization or blood transfusion) - Requirement for anti-platelet medication ...

3. Donepezil (Transdermal Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

4. Tafenoquine (Oral Route) Description and Brand Names - Mayo Clinic

   Tafenoquine belongs to a group of medicines, called antiprotozoals. It works by treating malaria, a red blood cell infection transmitted by the bite of a ...

5. A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... treatment and evaluate evidence of treatment efficacy. ... anti-HCV antibody screening test is positive); ...

6. Fezolinetant (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

7. Risperidone (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

8. Acupuncture - Care at Mayo Clinic

   Mayo Clinic treatment rooms dedicated to acupuncture have soft music and gentle lighting. This helps create an optimal relaxation response while your ...

9. A Phase 1-2 Multi-Center Study Evaluating Axicabtagene Ciloleucel in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1) - Mayo Clinic

   ... anti-CD19 chimeric antigen receptor (CAR)-positive T cell therapy, in refractory aggressive Non-Hodgkin Lymphoma (NHL). Participation eligibility.

10. A Study to Evaluate CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma - Mayo Clinic

    By condition, treatment or drug name ... Drugs used in chemotherapy, such as dexamethasone ... Patients who have not recovered from AEs due to prior anti ...